Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Mar. 31, 2024
Current Assets
Cash and cash equivalents	$ 2,429	$ 5,167
Accounts receivable, net of allowance for credit losses of $84 and $269, respectively	14,814	15,106
Employee retention tax credit	79	1,671
Content advances	10,788	9,345
Other current assets	2,069	1,432
Total current assets	30,179	32,721
Property and equipment, net	2,932	2,276
Intangible assets, net	17,937	18,328
Goodwill	6,799	6,799
Content advances, net of current portion	1,472	2,551
Other long-term assets	1,281	1,703
Total Assets	60,600	64,378
Current Liabilities
Accounts payable and accrued expenses	19,928	20,817
Line of credit, including unamortized debt issuance costs of $180 and $81, respectively	4,637	6,301
Current portion of deferred consideration on purchase of business	3,040	3,114
Earnout consideration on purchase of business	0	180
Current portion of operating lease liabilities	273	401
Deferred revenue	352	436
Total current liabilities	31,377	31,249
Deferred consideration on purchase of business, net of current portion		457
Operating lease liabilities, net of current portion	371	462
Other long-term liabilities	61	59
Total Liabilities	31,809	32,227
Commitments and contingencies (see Note 6)
Stockholders’ Equity
Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; 7 shares issued and 7 shares outstanding at September 30, 2024 and March 31, 2024	3,559	3,559
Common Stock, $0.001 par value; Class A Stock: 275,000,000 shares authorized as of September 30, 2024, and March 31, 2024; 16,287,824 and 15,985,620 shares issued, with 15,786,074 and 15,699,135 shares outstanding as of September 30, 2024 and March 31, 2024, respectively	194	194
Additional paid-in capital	547,234	545,996
Treasury stock, at cost; 503,819 and 288,554 shares as of September 30, 2024 and March 31, 2024, respectively	(12,193)	(11,978)
Accumulated deficit	(508,691)	(504,153)
Accumulated other comprehensive loss	(297)	(345)
Total stockholders' equity of Cineverse Corp.	29,806	33,273
Deficit attributable to noncontrolling interest	(1,015)	(1,122)
Total equity	28,791	32,151
Total Liabilities and Equity	60,600	$ 64,378
Terrifier 3 Financing [Member]
Current Liabilities
Term loan, including unamortized debt issuance costs of $87 and $0, respectively	$ 3,147